| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |